Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enovis (ENOV)
NYSE:ENOV
ENOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$38.27 - $63.96
Previous CloseN/A
Volume391.51K
Average Volume (3M)987.54K
Market Cap
$2.50B
Enterprise Value$3.81B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.22
Next Earnings
Feb 26, 2025EPS Estimate
0.92Last Dividend Ex-Date
Apr 05, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-2.17
Shares Outstanding56,859,173
10 Day Avg. Volume527,612
30 Day Avg. Volume987,541
Standard Deviation0.17
R-Squared0.51
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)11.50
P/FCF Ratio45.70
Enterprise Value/Market Cap1.53
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.85
Enterprise Value/Ebitda-56.21
Forecast
1Y Price Target
$68.50Price Target Upside60.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Enovis News
PremiumCompany Announcements
Enovis Highlights Growth at J.P. Morgan Conference
PremiumCompany Announcements
Enovis Corporation Reports Strong Sales Growth in Q3 2024---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceENOV posted a good quarter beating slightly on the top line and delivering robust proforma bottom line performance.
Growth StrategyENOV is setting up its portfolio and commercial channel to go on the offensive as dyssynergies moderate, with important launches expected in shoulder and hip.
Bears Say
Lack Of Investor ConfidenceThis lack of beats and/or raises from ENOV has been a point of frustration for some investors recently.
---
Ownership Overview
1.38% Insiders
39.46% Mutual Funds
0.80% Other Institutional Investors
32.35% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ENOV FAQ
What was Enovis’s price range in the past 12 months?
Enovis lowest stock price was $38.27 and its highest was $63.96 in the past 12 months.
What is Enovis’s market cap?
Enovis’s market cap is $2.50B.
When is Enovis’s upcoming earnings report date?
Enovis’s upcoming earnings report date is Feb 26, 2025 which is in 4 days.
How were Enovis’s earnings last quarter?
Enovis released its earnings results on Nov 06, 2024. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.616 by $0.114.
Is Enovis overvalued?
According to Wall Street analysts Enovis’s price is currently Undervalued.
Does Enovis pay dividends?
Enovis pays a Notavailable dividend of $16.666 which represents an annual dividend yield of N/A. See more information on Enovis dividends here
What is Enovis’s EPS estimate?
Enovis’s EPS estimate is 0.92.
How many shares outstanding does Enovis have?
Enovis has 56,859,173 shares outstanding.
What happened to Enovis’s price movement after its last earnings report?
Enovis reported an EPS of $0.73 in its last earnings report, beating expectations of $0.616. Following the earnings report the stock price went up 8.289%.
Which hedge fund is a major shareholder of Enovis?
Currently, no hedge funds are holding shares in ENOV
---
Enovis Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$68.50 (60.38% Upside)
$68.50 (60.38% Upside)
Blogger Sentiment
Bullish
ENOV Sentiment 100%
Sector Average 66%
Sector Average 66%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 5.3%
Last 30 Days ▲ 5.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-29.13%
12-Months-Change
Fundamentals
Return on Equity
-3.59%
Trailing 12-Months
Asset Growth
26.11%
Trailing 12-Months
Company Description
Enovis
Colfax Corp. operates as a diversified technology company that provides orthopedic care and fabrication technology products and services to customers. The firm operates its business through the following segments: Medical Technology; and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices with a broad range of products used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures, and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Annapolis Junction, MD.
---
ENOV Company Deck
---
ENOV Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive trajectory with strong revenue growth and successful integration efforts, despite some market disruptions and anticipated dis-synergies impacting short-term guidance. The company's performance remains strong with expectations for future growth.Read More>---
ENOV Stock 12 Month Forecast
Average Price Target
$68.50
▲(60.38% Upside)
Technical Analysis
Best Analysts Covering ENOV
1 Year
1 Year Success Rate
3/13 ratings generated profit
1 Year Average Return
-10.55%
reiterated a buy rating 4 months ago
Copying Jeff Johnson's trades and holding each position for 1 Year would result in 23.08% of your transactions generating a profit, with an average return of -10.55% per trade.
---